M&T Bank Corp reduced its stake in CME Group Inc. (NASDAQ:CME – Get Rating) by 0.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 74,757 shares of the financial services provider’s stock after selling 112 shares during the period. M&T Bank Corp’s holdings in CME Group were worth $13,242,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of the stock. RB Capital Management LLC boosted its holdings in CME Group by 11.4% in the first quarter. RB Capital Management LLC now owns 1,419 shares of the financial services provider’s stock worth $338,000 after purchasing an additional 145 shares during the last quarter. Prudential PLC purchased a new stake in CME Group in the 1st quarter worth approximately $1,709,000. Cetera Investment Advisers increased its holdings in CME Group by 5.8% in the 1st quarter. Cetera Investment Advisers now owns 3,485 shares of the financial services provider’s stock worth $829,000 after acquiring an additional 190 shares in the last quarter. Sequoia Financial Advisors LLC purchased a new stake in CME Group in the 1st quarter worth approximately $281,000. Finally, Candriam Luxembourg S.C.A. increased its holdings in CME Group by 9.5% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 25,230 shares of the financial services provider’s stock worth $6,001,000 after acquiring an additional 2,181 shares in the last quarter. Hedge funds and other institutional investors own 85.09% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts have weighed in on CME shares. Citigroup dropped their price target on CME Group from $214.29 to $210.00 in a research note on Thursday, January 12th. UBS Group lowered their target price on CME Group from $226.00 to $220.00 in a research report on Thursday, January 5th. Morgan Stanley increased their price target on CME Group from $196.00 to $201.00 and gave the company an “equal weight” rating in a report on Monday, February 13th. Deutsche Bank Aktiengesellschaft increased their target price on CME Group from $200.00 to $218.00 in a research note on Thursday, February 9th. Finally, Piper Sandler reduced their target price on CME Group from $270.00 to $250.00 and set an “overweight” rating on the stock in a research note on Monday, December 19th. One analyst has rated the stock with a sell rating, four have given a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $219.83.
CME Group Stock Down 1.5 %
CME Group (NASDAQ:CME – Get Rating) last posted its quarterly earnings data on Wednesday, February 8th. The financial services provider reported $1.92 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.02. The business had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.21 billion. CME Group had a return on equity of 10.43% and a net margin of 53.61%. The business’s revenue was up 5.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.66 earnings per share. On average, analysts anticipate that CME Group Inc. will post 8.46 EPS for the current fiscal year.
CME Group Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, March 27th. Stockholders of record on Friday, March 10th will be paid a $1.10 dividend. The ex-dividend date is Thursday, March 9th. This is a positive change from CME Group’s previous quarterly dividend of $1.00. This represents a $4.40 dividend on an annualized basis and a dividend yield of 2.41%. CME Group’s payout ratio is currently 59.54%.
CME Group Company Profile
CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.
Featured Stories
- Get a free copy of the StockNews.com research report on CME Group (CME)
- Meta Platforms: Efficiency Gains Momentum, Stock Accelerates
- Pfizer’s Latest Acquisition Strengthens the Case for PFE Stock
- SentinelOne: Reversal In-Play For Cybersecurity Stocks
- Is Sportradar Group A Growth Stock To Bet On In 2023?
- Strong Guidance says Boeing is Ready for Takeoff
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.